HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eve-Lyne Marchand Selected Research

benzyloxycarbonyl- valyl- alanyl- (methyl)aspartic acid fluoromethyl ketone

4/2003Caspase-dependent cell death mediates the early phase of aortic hypertrophy regression in losartan-treated spontaneously hypertensive rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eve-Lyne Marchand Research Topics

Disease

2Vascular Remodeling
07/2004 - 04/2003
2Hypertrophy
07/2004 - 04/2003
1Hypertension (High Blood Pressure)
04/2003
1Hyperplasia
03/2003
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
03/2003

Drug/Important Bio-Agent (IBA)

2EnalaprilFDA LinkGeneric
07/2004 - 03/2003
1EnzymesIBA
04/2003
1benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA
04/2003
1benzyloxycarbonyl- valyl- alanyl- (methyl)aspartic acid fluoromethyl ketoneIBA
04/2003
1AngiotensinsIBA
04/2003
1Losartan (Cozaar)FDA LinkGeneric
04/2003
1CaspasesIBA
04/2003
1Valsartan (Vals)FDA Link
03/2003